Proceeds to drive development of ONP-002, the Company’s lead intranasal drug candidate for mild traumatic brain injurySARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful closing of its previously announced public offering of Series H Convertible Preferred Stock and Warrants. The Company secured total gross proceeds of approximately $16.5 mi ...

FONAR Board of Directors Appoints Independent DirectorJuly 02, 2025 4:10 PM EDT | Source: Fonar CorporationMelville, New York--(Newsfile Corp. - July 2, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the Company's board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position ...

WESTPORT, Conn., July 02, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash distribution for each of its three preferred share series. This announcement underscores that in the wake of its ongoing investigation of Lugano, the Company’s diversified business model supports its continued ability to generate strong cash flow. The Board declared ...

ATHENS, Greece, July 02, 2025 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that its Board of Directors has called an annual meeting of the shareholders to be held on July 23, 2025, at 11:00 a.m. at the offices of Seward & Kissel LLP, located at 901 K Street NW, Suite 800, Washington, DC 20001. Shareholders of record at the close of business on June 25, 2025, are entitled ...

Acclarent AERA® Eustachian Tube Balloon Dilation System First Patient Enrolled in Acclarent AERA® Pediatric Registry PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a prospective, multi-center observational registry evaluating the real-world use of the AERA Eustachian Tube Balloon Dilation System in childre ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT). Shareholders who purchased shares of SRPT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/sarepta-loss-submission-form/?id=155065&from=3 CLASS PERIOD: June 22, 2 ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE). Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fortrea-holdings-inc-loss-submission-form/?id=155066&from=3 CLASS PERIOD: Ju ...

Rocket Lab Corporation (NASDAQ: RKLB ) stock has been flying, up 91% since I initiated my coverage back in mid-March. The success rate for its rocket launches in 2025 has been at 100%, and that's not to mentionI’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI boom. In one word, what I’d like ...

LONDON, July 02, 2025 (GLOBE NEWSWIRE) --  NE10 Vodka Limited, (“NE10”) and/or (the” Company”) a leading international drinks business with a strong emphasis on the production and distribution of premium flavored vodka and ready-to-drink cans, today announced the appointment of two seasoned Directors, further strengthening the Company’s executive leadership team. With immediate effect, Scott Ryder and Simon Young will take their positions as National Sales and Commercial Directors respectively. Scott brings ...

Group 1 - EQT is currently trading at $55.87, showing a 0.3% increase, but is struggling to recover from a recent decline from its peak of $61.02 on June 23 [1] - The stock has a support level at $55, which was previously a resistance level, and is following a historically bullish trendline just below this point [1] - Year-to-date, EQT shares have increased by 22%, indicating potential for further upward movement [1] Group 2 - According to Rocky White, EQT is within one standard deviation of its 50-day moving average, having been above this trendline in 8 of the last 10 trading days and spending 80% of the last two months above it [2] - Historical data shows that similar conditions have led to a 67% chance of the stock being higher one month later, with an average increase of 5.5% [2] - A comparable increase could bring EQT's price close to $60, nearing its record high [2] Group 3 - The current Schaeffer's Volatility Index (SVI) for EQT is 34%, which ranks in the 12th percentile of its annual range, indicating that options traders are anticipating low volatility [3]